Literature DB >> 6229569

Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease.

D A Weiner, T J Ryan, C H McCabe, B R Chaitman, L T Sheffield, J C Ferguson, L D Fisher, F Tristani.   

Abstract

To identify predictors of mortality in medically treated patients with symptomatic coronary artery disease, 30 variables were analyzed in 4,083 patients. Regression analysis demonstrated that seven variables were independent predictors of survival. A high risk subgroup (annual mortality rate above 5%) was identified, consisting of patients with either a congestive heart failure score of 3 to 4 or 1 mm or greater ST segment depression and final exercise stage of 1 or less. When all 30 variables were analyzed conjointly, the left ventricular contraction pattern (p less than 0.0001) and the number of diseased coronary vessels (p less than 0.003) proved to be the most important predictors of survival. In a subgroup of 572 patients with three vessel coronary disease and preserved left ventricular function, the probability of survival at 4 years ranged from 53% for patients only able to achieve stage 1/2 of exercise to 100% for patients able to exercise into stage 5 (p less than 0.004). Thus, in patients with defined coronary pathoanatomy, clinical and exercise variables primarily relating to the functional state of the left ventricle are helpful in assessing prognosis.

Entities:  

Mesh:

Year:  1984        PMID: 6229569     DOI: 10.1016/s0735-1097(84)80254-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  Drugs and exercise testing.

Authors:  T Millane; D Ward
Journal:  BMJ       Date:  1992-10-31

2.  Contemporary relevance of TID: Based on the company it keeps.

Authors:  Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

Review 3.  Return-to-work evaluation after coronary events. Special emphasis on simulated work activity.

Authors:  J Landes; J L Rod
Journal:  Sports Med       Date:  1992-06       Impact factor: 11.136

Review 4.  Physiologic risk assessment in stable ischemic heart disease: still superior to the anatomic angiographic approach.

Authors:  Alessia Gimelli; Paolo Marzullo; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2009-07-28       Impact factor: 5.952

5.  Exercise testing to predict outcome in patients with angina.

Authors:  M A Hlatky
Journal:  J Gen Intern Med       Date:  1999-01       Impact factor: 5.128

6.  Preoperative cardiac risk assessment for noncardiac surgery.

Authors:  J A Leppo
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

7.  Diagnostic and prognostic exercise electrocardiography: what can nuclear cardiology gain from insights from the exercise laboratory--challenge and speculation.

Authors:  B R Chaitman; D D Miller
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

8.  Prognosis and thallium-201 scintigraphy in patients admitted with chest pain without confirmed acute myocardial infarction.

Authors:  J K Madsen; M Stubgaard; H E Utne; J F Hansen; K van Duijvendijk; J H Reiber; K Christoffersen
Journal:  Br Heart J       Date:  1988-02

9.  Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.

Authors:  Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'Brien; Karen P Alexander; Roxy Senior; William E Boden; Gregg W Stone; Shaun G Goodman; Renato D Lopes; Jose Lopez-Sendon; Harvey D White; Aldo P Maggioni; Leslee J Shaw; James K Min; Michael H Picard; Daniel S Berman; Bernard R Chaitman; Daniel B Mark; John A Spertus; Derek D Cyr; Balram Bhargava; Witold Ruzyllo; Gurpreet S Wander; Alexander M Chernyavskiy; Yves D Rosenberg; David J Maron
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

10.  Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.

Authors:  Ishak A Mansi; Jenny English; Song Zhang; Eric M Mortensen; Ethan A Halm
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.